The FDA has authorized the first wearable device capable of continuously monitoring both ketone levels and blood sugar simultaneously. This represents a significant advancement for diabetes management, particularly for Type 1 diabetic patients who need to track ketones to detect diabetic ketoacidosis risk.
Background
Continuous glucose monitors (CGMs) have become standard for diabetes management, but ketone monitoring has required separate blood tests. No wearable device has previously offered simultaneous tracking of both biomarkers.
- Source
- Hacker News (RSS)
- Published
- Aug 26, 2026 at 03:07 AM
- Score
- 7.0 / 10